To understand if elevated LAS1L expression in breast cancer provides insight into prognosis, we assessed publicly available RNAseq—IlluminaHiSeq for 1101 breast cancer primary tumors (cohort: TCGA Breast Cancer BRCA) using Xena browser37. This evidence concerns the gene LAS1L and breast carcinoma.